Ono Pharmaceutical Co. (OPHLF) Soars 13.9%: Is Further Upside Left in the Stock?
NRX Pharmaceuticals Inc NRXP
$2.92
▲ +1.74%
(+$0.05)
🔥 High Short Interest
🎢 High Beta
Open
$2.92
Prev Close
$2.87
Day Range
$2.87 – $2.97
52W Range
$1.62 – $5.06
Market Cap
$126.42M
Beta
2.07
EPS (TTM)
$-0.74
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2017-11-20 |
| Shares Out. | 36,230,000 |
| Website | nrxpharma.com/ ↗ |
| Phone | 13025750877 |
| Employees | 29 |
| Revenue | $1.1M |
| Gross Profit | $426,000 |
| Net Income | -$16.5M |
| Free Cash Flow | -$20.7M |
| Total Assets | $34.2M |
| Total Liabilities | $34.3M |
| Equity | -$170,000 |
About NRX Pharmaceuticals Inc
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
NRX Pharmaceuticals Inc is a publicly traded company under the ticker symbol NRXP on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
11 analysts (2026-09-01)